Patents by Inventor Masaharu Fukami

Masaharu Fukami has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment and prophylaxis of pancreatitis
    Patent number: 5753681
    Abstract: Insulin sensitizers, especially thiazolidinedione compounds, such as troglitazone, are useful for the treatment and prevention of pancreatitis.
    Type: Grant
    Filed: March 17, 1997
    Date of Patent: May 19, 1998
    Assignee: Sankyo Company, Limited
    Inventors: Toshihiko Fujiwara, Hiroyoshi Horikoshi, Masaharu Fukami
  • Ocular hypotensive agents
    Patent number: 5273976
    Abstract: Pharmaceutical compositions and methods for treatment of eye disorders employ ocular hypotensive compounds of the formula (I) ##STR1## wherein R.sup.1 is selected from hydrogen, C.sub.1 -C.sub.6 alkyl, and C.sub.1 -C.sub.6 alkoxy; each R.sup.2 is selected from hydrogen, C.sub.1 -C.sub.6 alkyl, halogen, nitro or carboxy; R.sup.3 is selected from amino, mono-substituted amino, and di-substituted amino; A and B each represents C.sub.1 -C.sub.6 alkylene, X represents --NH-- or --CH.sub.2 -- and n is 1, 2 or 3; and pharmaceutically acceptable salts or esters thereof.
    Type: Grant
    Filed: October 22, 1992
    Date of Patent: December 28, 1993
    Assignee: Sankyo Company, Limited
    Inventors: Tomihisa Yokoyama, Masaharu Fukami, Mitsuru Kataoka
  • Occular hypotensive agents
    Patent number: 5175161
    Abstract: Pharmaceutical compositions and methods for treatment of eye disorders employ ocular hypotensive compounds of the formula (I); ##STR1## (wherein: R.sup.1 is selected from hydrogen, C.sub.1 -C.sub.6 alkyl, and C.sub.1 -C.sub.6 alkoxy;each R.sup.2 is selected from hydrogen, C.sub.1 -C.sub.6 alkyl, halogen, nitro or carboxy;R.sup.3 is selected from heterocyclic, amino, mono-substituted amino, and di-substituted amino,A and B each represents C.sub.1 -C.sub.6 alkylene,X represents --NH-- or --CH.sub.2 --; and n is 1, 2 or 3)or pharmaceutically acceptable salts or esters thereof.
    Type: Grant
    Filed: April 3, 1990
    Date of Patent: December 29, 1992
    Assignee: Sankyo Company, Limited
    Inventors: Tomihisa Yokoyama, Masaharu Fukami, Mitsuru Kataoka
  • Ophthalmic anti-inflammatory agents
    Patent number: 4599360
    Abstract: Compounds of formula: ##STR1## (wherein R represents hydrogen or methyl, >A--B-- represents a >CH--CH.sub.2 -- or >C.dbd.CH-- group; >C--Z represents a >C.dbd.O or >CH--OH group; and n represents 1 or 2) and ophthalmically acceptable salts and esters thereof are useful as ophthalmic anti-inflammatory agents.
    Type: Grant
    Filed: August 9, 1984
    Date of Patent: July 8, 1986
    Assignee: Sankyo Company Limited
    Inventors: Masaharu Fukami, Atsusuke Terada, Kazue Hasegawa